Bioventus (BVS) Shareholder's Equity (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn | 188.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 188.90 Mn |
| Dec 31, 2025 | 228.45 Mn |
| Sep 27, 2025 | 166.10 Mn |
| Jun 28, 2025 | 201.30 Mn |
| Mar 29, 2025 | 185.48 Mn |
| Dec 31, 2024 | 185.60 Mn |
| Sep 28, 2024 | 186.83 Mn |
| Jun 29, 2024 | 189.06 Mn |
| Mar 30, 2024 | 217.43 Mn |
| Dec 31, 2023 | 221.12 Mn |
| Sep 30, 2023 | 226.46 Mn |
| Jul 1, 2023 | 233.34 Mn |
| Apr 1, 2023 | 240.36 Mn |
| Dec 31, 2022 | 412.22 Mn |
| Oct 1, 2022 | 451.04 Mn |
| Jul 2, 2022 | 592.08 Mn |
| Apr 2, 2022 | 593.81 Mn |
| Dec 31, 2021 | 607.66 Mn |
| Oct 2, 2021 | 152.50 Mn |
| Jul 3, 2021 | 219.36 Mn |
| Apr 3, 2021 | 220.28 Mn |
| Dec 31, 2020 | 144.16 Mn |
| Jun 27, 2020 | 141.79 Mn |
| Mar 28, 2020 | 155.59 Mn |